These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19460515)

  • 1. Adacolumn treatment in kidney transplant patients with hepatitis C virus.
    Novelli G; Rossi M; Ferretti G; Poli L; Pretagostini R; Ruberto F; Morabito V; Cinti P; Nudo F; Mennini G; Berloco PB
    Transplant Proc; 2009 May; 41(4):1195-200. PubMed ID: 19460515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adacolumn apheresis for hepatitis C virus in patients waiting for kidney transplant. Preliminary study].
    Novelli G; Ferretti G; Morabito V; Cinti P; Poli L; Pretagostini R; Berloco PB
    G Ital Nefrol; 2012; 29 Suppl 54():S109-13. PubMed ID: 22388840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
    Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
    Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus.
    Sawada K; Kashiwamura S; Okamura H; Ohnishi K; Fukunaga K; Hirata I; Saniabadi A
    Dig Liver Dis; 2005 Jul; 37(7):515-21. PubMed ID: 15975539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis.
    Novelli G; Rossi M; Morabito V; Ferretti G; Pretagostini R; Ruberto F; Pugliese F; Guglielmo N; Berloco PB
    Transplant Proc; 2012 Sep; 44(7):1946-52. PubMed ID: 22974879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia.
    Sawada K; Masaki N; Hayashi S; Zeniya M; Ishikawa T; Takahashi H; Ohnishi K; Fukunaga K; Hara N; Yamamoto T; Hada T; Toda G
    J Viral Hepat; 2005 May; 12(3):274-82. PubMed ID: 15850468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1.
    Diepolder HM; Kashiwagi N; Teuber G; Ulsenheimer A; Franz M; Yokoyama T; Zachoval R
    J Med Virol; 2005 Oct; 77(2):209-15. PubMed ID: 16121358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C.
    Moriyama M; Kaneko M; Matsumura H; Fukushima A; Aoki H; Tanaka N; Kuroda K; Shimizu K; Hiraishi K; Arakawa Y
    Intervirology; 2005; 48(2-3):84-8. PubMed ID: 15812179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.
    Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T
    J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study.
    Morabito V; Novelli S; Poli L; Ferretti G; Ruberto F; Pugliese F; Pretagostini R; Berloco PB; Rossi M
    Transplant Proc; 2016 Mar; 48(2):352-8. PubMed ID: 27109954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of interferon alfa treatment in chronic hepatitis C in relation to the serum concentration of RNA-HCV and the viral genotype].
    Hermida M; Castro A; López S; Vega P; Pedreira J
    An Med Interna; 1997 Oct; 14(10):500-5. PubMed ID: 9424139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
    Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
    Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
    Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
    Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics].
    Husa P; Slesinger P; Stroblová H; Svobodník A; Husová L
    Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):67-73. PubMed ID: 18756436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of extracorporeal granulocyte and monocyte adsorption apheresis in patients with severe persistent bronchial asthma.
    Ishizuka T; Kawata T; Shimizu Y; Utsugi M; Endou K; Hisada T; Dobashi K; Nakazawa T; Mori M
    Inflammation; 2005 Feb; 29(1):9-16. PubMed ID: 16502341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.